Abstract. Prostate cancer (PC) is the most frequently diagnosed cancer in Ecuador (15.6%). The androgen receptor gene codes for a protein that has an androgen-binding domain, DNA-binding domain and N-terminal domain, which contains two polymorphic trinucleotide repeats (CAG and GGC). The aim of the present study was to determine whether variations in the number of repetitions of CAG and GGC are associated with the pathological features and the risk of developing PC. The polymorphic CAG and GGC repeat lengths in 108 mestizo patients with PC, 148 healthy mestizo individuals, and 78 healthy indigenous individuals were examined via a retrospective case-control study. Genotypes were determined by genomic sequencing. The results demonstrated that patients with ≤21 CAG repeats have an increased risk of developing PC [odds ratio (OR)=2.99, 95% confidence interval (CI) =1.79-5.01; P<0.001]. The presence of ≤21 CAG repeats was also associated with a tumor stage ≥T2c (OR=4.75; 95% CI=1.77-12.72; P<0.005) and a Gleason score ≥7 (OR=2.9; 95% CI=1.1-7.66; P=0.03). In addition, the combination of ≤21 CAG and ≥17 GGC repeats was associated with the risk of developing PC (OR=2.42; 95% CI=1.38-4.25; P=0.002) and with tumor stage ≥T2c (OR=2.77; 95% CI=1.13-6.79; P=0.02). In conclusion, the histopathological characteristics and PC risk in Ecuadorian indigenous and mestizo populations differs in association with the CAG repeats, and the combination of CAG and GGC repeats.
Introduction
Prostate cancer (PC) represents a significant health problem that involves hormonal, environmental, genetic and hereditary factors. PC is the second most commonly diagnosed type of cancer in males, representing ~15% of all new cancer cases in 2015 (1, 114 ,072 cases) (1) . Worldwide, the areas with a higher incidence of PC cases per 100,000 inhabitants are Oceania (101.9), North America (97.2) and Western Europe (94.9) (1-3). In Ecuador, 33% of all carcinoma diagnoses in males are prostate cancer, with an increase in the incidence from 23.7 per 100,000 inhabitants in 1985 to 54.4 in 2012 (1) (2) (3) (4) . Furthermore, the mortality rate associated with PC was 18.12 per 100,000 inhabitants in Ecuador in 2012 (1) (2) (3) (4) (5) .
The prostate is an androgen-dependent organ whose cell cycle is mediated by the interaction between the receptor and androgens. Genes that are involved in the signaling pathways and metabolism of these hormones have been implicated as factors involved in the initiation or progression of prostate adenocarcinoma (6) . The androgen receptor (AR) gene is located on chromosome Xq12 and encodes a protein that has three major functional domains: The N-terminal domain (NTD), DNA-binding domain and ligand-binding domain ( Fig. 1A) (7) . The NTD, encoded by exon 1, regulates the transactivation of target genes and contains two polymorphic trinucleotide repeats: CAG and GGC, encoding polyglutamine and polyglycine, respectively (Fig. 1B) (7) . The length of the CAG repeats correlates inversely with the AR transactivation function (8, 9) . In certain studies, a low number of CAG repeats has been associated with an increased risk of PC (10) (11) (12) (13) (14) . However, other groups have not identified these repetitions as a risk factor, suggesting that this factor is less relevant (15) (16) (17) . The effects of GGC repeats on transcription are also unclear (18, 19) . Certain studies have demonstrated an association of short GGN or GGC repeats with PC (13, 14) , while others have demonstrated a correlation with long repeats (20) , and the majority of studies have not been able to establish any association with risk or protection (15, 21) .
The variants reported in the CAG and GGC repeats are highly polymorphic and associated with ethnic factors, thus, it may be important to determine their association with PC in different populations. The present study analyzed the polymorphic CAG and GGC repeats as possible risk factors for 
Materials and methods
Biological samples. The Bioethics Committee of the University of the Americas (Quito, Ecuador) approved this retrospective case-control study following the Declaration of Helsinki. This study was performed to determine the association between CAG and GGC repeats and the risk of PC and histopathological characteristics of prostate tumors. A total of 334 individuals were analyzed; 108 mestizo patients had a clinical diagnosis of prostate adenocarcinoma and 148 mastizo patients were healthy. Additionally, 78 healthy indigenous individuals were analyzed to determine the variety of trinucleotide repeats between different ethnic groups. The tumor samples were obtained from the Department of Pathology at the Carlos Andrade Marin Hospital (Quito, Ecuador) and the Oncological Hospital Solon Espinoza Ayala (Quito, Ecuador) from 2006 to 2008. Each case history conferred relevant information, such as age at diagnosis, preoperative prostate specific antigen levels (PSA), Gleason score, pTNM (tumor, nodule, metastasis), seminal vesicle invasion and surgical margin. The control group was selected randomly during the health check. They presented ethnic and geographical similarity to the affected individuals. Moreover, the controls did not have a history of cancer, exposure to genotoxics or consumption of alcohol or tobacco usage. Samples of the native population were collected from individuals who were self-recognized as indigenous from the Carchi, Imbabura, Cotopaxi, Bolivar, Cañar and Azuay Andean provinces; and the Canari, Otavalo, Pasto, Karanki, Kichwa and Wuarango communities. Furthermore, all participants included in the study signed an informed consent form.
DNA extraction and purification. DNA extraction and purification of case and control sample was performed using the PureLink Genomic DNA kit (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA). The DNA of the affected individuals, which presented an average concentration of 80 ng/µl, was extracted from ten sections (5 µm) of formalin-fixed paraffin-embedded prostate tumor tissue previously cut with a CUT 6062 microtome (SLEE, Mainz, Germany) and removed with Xylol. The DNA of the healthy mestizo individuals and the healthy indigenous individuals was extracted from peripheral blood samples and buccal swabs, respectively. The average concentration was 135 ng/µl as determined using a NanoDrop 2000 (Thermo Fisher Scientific, Inc.).
Genotyping. Genotyping was performed using the polymerase chain reaction (PCR) technique and DNA sequencing analysis. A final volume of 50 µl DNA was used for each PCR reaction for the trinucleotide repeat polymorphisms CAG and GGC. Each reaction consisted of 4 µl DNA template (50-100 ng), 0.2 µM of each deoxynucleotide triphosphate (dNTPs), 3 mM MgCl 2 , 5 µl of 10X buffer (500 mM KCl and 200 mM Tris-HCl, pH 8.4), 0.5 units of AccuPrime kit GC-Rich DNA Polymerase (Invitrogen; Thermo Fisher Scientific, Inc.), 0.0008 mmol/l dimethyl sulfoxide, 34 µl Milli-Q water and 0.4 µM of each primer. The primer sequences were as follows: Forward, 5'-TCC AGA ATC TGT TCC AGA GCG TGC -3' and reverse, 5'-GCT GTG AAG GTT GCT GTT CCT CAT -3' for the CAG repeats; and forward, 5'-TCC AGA ATC TGT TCC AGA GCG TGC -3' and reverse, 5'-GCT GTG AAG GTT GCT GTT CCT CAT -3' for the GGC repeats.
The amplification program of the polymorphic CAG repeat length consisted of 5 min at 95˚C, followed by 32 cycles of 45 sec at 95˚C, 30 sec at 61˚C, 30 sec at 72˚C, and 5 min at 72˚C. The amplification program of the polymorphic GGC repeat length consisted of 2 min at 95˚C, followed by 28 cycles of 30 sec at 95˚C, 30 sec at 59˚C, 45 sec at 72˚C, and 5 min at 72˚C. Each run was completed using a Sure Cycler 8800 thermocycler (Agilent Automation Solutions, Santa Clara, CA, USA).
The products obtained were genotyped through sequence analysis using a Genetic Analyzer 3130 (Applied Biosystems, Austin, TX, USA). The final volume of each reaction was 9.8 µl and contained 2.8 µl Milli-Q water, 2 µl of 5X buffer, 1 µl forward primers (3.2 pmol), 1 µl BigDye Terminator v3.1 sequencing standard (Applied Biosystems), and 3 µl of PCR product (3-10 ng). Once the product was amplified, it was then purified using Agentcourt Cleanseq (Beckman Coulter, Miami, FL, USA). The amplification program consisted of 3 min at 96˚C, followed by 30 cycles of 10 sec at 96˚C, 5 sec at 50˚C, and 4 min at 60˚C (22) . Finally, sequence analysis was performed using Sequencing Analysis Software 5.3.1 (Applied Biosystems), and the alignment with sequences from GeneBank (AR NC_000023) was performed using Seq-Scape Software v2.6 (Applied Biosystems).
Statistical analysis. The information from the clinical records of the patients was collected and stored in a database. The frequency of the GGC-CAG repeats in the three study groups was determined by descriptive statistical analysis. In the case-control study, samples from the indigenous population were not included as there were no prostate tumor sections from indigenous patients. The CAG and GGC repeats were categorized into two groups (≤21 vs. ≥22 and ≤16 vs. ≥16, respectively). Categories were used according to those in previous studies, analyzed separately and combined (15, 16) .
The association between the number of repetitions with the risk of developing PC and with the pathological characteristics tumor stage (<T2c vs. ≥T2c), Gleason score (2-6 vs. 7-10), PSA (<20 vs. ≥20), surgical margins and vesicular invasion (present vs. absent) was determined by odds ratio (OR), 95% confidence interval (CI), 2x2 contingency tables and the χ 2 test. P<0.05 was considered to indicate a statistically significant difference. These analyses were performed using IBM SPSS Statistics 22 software (IBM, Armonk, NY, USA).
Results

Clinical characteristics of study participants.
Clinical information of the 108 cases of prostate cancer is detailed in Table I . The mean age at diagnosis was 69 years. Of these patients, there was information for 87 individuals (81%) concerning the tumor stage and Gleason level, 27 (25%) in relation to the invasion of seminal vesicles and 94 (87%) regarding PSA levels. From all the cases, only 8 (7.41%) had metastases to organs, such as the testes, liver, skull, sternum and spine.
Determination of CAG repeats. Regarding the CAG repeats, the patient group presented with 12-30 repetitions with an average of 20. The most common number of CAG repeats were 21 and 22 (15.7 and 12%, respectively). The mestizo control group had 16-30 repetitions with an average of 22. The most common number of CAG repeats were 22 (25.7%) and 25 (12.8%). In the indigenous population, the repeat size ranged from 18 to 29 CAGs, determining the highest average of the three groups corresponding to 24 repetitions (Fig. 1B) . Thus, the most common number of CAG repeats were 24 and 26, both with 24.4%. Statistically significant differences (P<0.001) in the distribution of these trinucleotides were demonstrated (≤21 CAGs vs. ≥22 CAGs).
Determination of GGC repeats. The total number of individuals analyzed for GGC repeats was 321 consisting of 243 mestizos (108 cases and 135 controls) and 78 indigenous individuals. In patient samples, the number of GGC trinucleotide repeats ranged from 13 to 18, with an average of 16. The most (Fig. 1B) . The most common number of GGC repeats were 17 (50%) and 18 (24.4%). The difference in the distribution of the GGC repeats in the three study groups was statistically significant (P<0.05). Table IV demonstrated the association between combinations CAG + GGC and pathological characteristics. The association between the trinucleotide combination ≤21 CAGs + ≥17 GGCs and the tumor stage (T1-T2b compared with T2c-T4) demonstrated an OR of 2.77 (95% CI, 1.13-6.79; P= 0.02), whereas the combination ≤21 CAGs + ≤16 GGCs demonstrated no significant association. Additionally, there was no significant association between the trinucleotide combinations and the Gleason grade, PSA, surgical margins, or seminal vesicle invasion.
OR of CAG and GGC repeats.
Discussion
Trinucleotide repeats are associated with human diseases and microsatellite instability (23) . Microsatellite instability affects gene expression and protein function (24) . In addition to PC, the polymorphic CAG repeats have been associated with skin disorders (25, 26) , breast cancer, polycystic ovary disease, Kennedy syndrome (27, 28) , azoospermia and oligospermia (29) . Furthermore, the effects of the repetition sequence GGC polyglycine have been associated with hypospadias and cryptorchidism (30, 31) ; however, its role in transcription is unclear.
The CAG and GGC repeats specifically vary depending on the ethnic group studied (32, 33) . The normal distribution of the CAG repeats is reported in a range of 6-39, with an average of 19-20 in African-Americans, 21-22 in Caucasians, 22-23 in Asians, and 23 in Hispanics (34) . In this study, the repeat range in the mestizo control group was 16-30, with an average of 22, resembling Asians and Caucasians. Other polymorphisms associated with PC in Ecuador also showed similar frequencies to Asians (35, 36) . Regarding South American countries, Brazil reported an average of 20.65 CAGs for a population of Caucasian and African descents (37) . In another study, Madjunkova et al (38) reported a mean repeat length of 21.5 CAGs in patients with PC from Macedonia. In a study that examined adenocarcinomas, the number of CAG repeats ranged from 12 to 30 and averaged 20, which was similar to that in a healthy Brazilian population. Moreover, these results were consistent with the average in cases (19 CAGs) and controls (19) (20) in African-Americans (17) , and in both, cases and controls (21.95 CAG) in Australians (39) .
The variation in the number of the GGC trinucleotides has also been demonstrated in several populations, however, it is less polymorphic than the CAG repeat (40) . In this study, the repeat range was 15-18 with an average of 17 GGCs for controls. These data are consistent with the normal range found in 90% of the world population (20) . The repeat average is 14-15 in African-American and African natives (14) , 16 in Asians (10), and 15-16 in Caucasian, European and Mediterranean populations (40) . GGC repeats <17 in controls have also been recorded in North American, Asian and African populations (10) . However, the number of GGC repeats in affected individuals was 13-18, with an average of 16. The ranges and averages of the CAG and GGC repeats in control mestizo population are similar to those of Asian and Caucasian-European populations. This may be because the mestizo Ecuadorian population is considered a trihybrid, containing genes originated from America and descendants of Native Asians, Europeans and Africans (41) .
A significant association between the presence of ≤21 CAGs, and PC and histopathologic characteristics was determined.
Our results indicated that in mestizos the PC risk increased 2.99 times in males with ≤21 CAGs, which is consistent with the results of some other studies (14, 42) . By contrast, some studies did not identify an association with this repetition (15, 16, 43, 44) .
Few studies have identified a similar correlation with the Gleason score and ≤21 CAG repeats. Thus, it is essential more research to establish an strong association between the Gleason score and the CAG repeats as a predictive parameter (45) (46) (47) .
Several studies reported no association between the GGC repeat lengths, the PC risk, and pathological characteristics (12,15,16 ), stating that there were no significant differences Table III . Association of polymorphic CAG and GGC repeats with histopathological characteristics. between cases and controls (48) . This information is consistent with the results of the Ecuadorian population. However, other studies demonstrated that there is a 4.6 fold increased risk of developing PC when the GGC repetition is present (14, 49, 50) . Failure to determine an association suggests that the transcriptional activity of the AR gene does not differ when there are 13-17 GGC repeats; thus within this range, gene activity is normal (19) . No association of risk or protection between cases and controls was reported with ≤21 CAGs+≤16 GGCs. Similarly, no association in the analysis of the clinicopathological variables was found. By contrast, the combination ≤21 CAGs+≥17 GGCs was correlated with a 2.42 times increased risk of developing PC. These results were consistent with other studies (10, 12, 16, 21) .
CAG repeats GGC repeats
The CAG and GGC repeats have been associated with PC in certain studies and discarded in others. As this is a complex and heterogeneous disease, an explanation of the discrepancy in the results is required. The main cause may be the variable androgen production in the different ethnic groups, the sample size or the criteria for selecting healthy controls. In Ecuador, indigenous communities represent 21% of the population (5), constituting a major ethnic group. The characterization of the CAG and GGC repeats in the indigenous population is of interest as to the best of our knowledge, these are the first records published. Thus, the average of 24 CAGs in the indigenous population was the highest average of the three groups. It demonstrated the similarity of this native population with Asian native populations, which are characterized by a low risk of developing PC. This may also suggest that the genetic ancestry of Native American groups originated in Asia, and were subsequently distributed throughout South America.
In conclusion, the risk of PC and the tumor characteristics differ in relation to the number CAG repeats, but not the number of GGC repeats. The information provided by the characterization of polymorphic CAG and GGC repeats must be interpreted with caution. Despite the results, the association between the number of trinucleotides and PC and clinical variables does not constitute definitive evidence for the repeats to be considered as molecular risk or poor prognosis markers.
In conclusion, the risk of PC and the tumor character istics differ in relation to the number CAG repeats, but not the number of GGC repeats. Analysis of microsatellite instability in the AR gene in the Ecuadorian heterogeneous populations (Mestizo and indigenous) is important. However, the information provided by the characterization of polymorphic CAG and GGC repeats must be interpreted with caution. Despite the results, the association between the number of trinucleotides and PC, and clinical variables, such as tumor stage, does not constitute definitive evidence for the repeats to be considered as molecular risk or poor prognosis markers. Thus, further studies in other repeat length polymorphisms and AR gene expression are required.
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